Association between interleukin-6 gene -174 G/C polymorphism and the risk of coronary heart disease: A meta-analysis of 20 studies including 9619 cases and 10,919 controls

Gene

Volumn 503, Issue 1, 2012, Pages 25-30

  Yin, Yan wei ^a   Hu, Ai min ^a   Sun, Qian qian ^b   Liu, Hong li ^a   Wang, Qi ^a   Zeng, Yi hua ^a   Xu, Rui jia ^a   Hou, Zhi zhen ^a   Zhang, Zhong dong ^a   Zhang, Shi jie ^a   Zhou, Ming qi ^a  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b Jinsong Sanatorium of Beijing Air Force   (China)

Author keywords

Coronary heart disease; Interleukin 6; Meta analysis; Polymorphism

Indexed keywords

INTERLEUKIN 6;

ARTICLE; ASIAN; CARDIOVASCULAR RISK; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK;

EID: 84861765771     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.04.075     Document Type: Article

References (39)

1. Banerjee I., Pandey U., Hasan O.M., Parihar R., Tripathi V., Ganesh S. Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J. Thromb. Thrombolysis 2009, 27:88-94.
2. Basso F., Lowe G.D., Rumley A., McMahon A.D., Humphries S.E. Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland Coronary Prevention Study (WOSCOPS). Arterioscler. Thromb. Vasc. Biol. 2002, 22:599-604.
3. Bennermo M., et al. Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study. J. Interferon Cytokine Res. 2011, 31:259-264.
4. Bennet A.M., et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 2003, 171:359-367.
5. Berkey C.S., Hoaglin D.C., Mosteller F., Colditz G.A. A random-effects regression model for meta-analysis. Stat. Med. 1995, 14:395.
6. Brull D.J., et al. Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1458-1463.
7. Burzotta F., et al. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am. J. Cardiol. 2001, 88:1125-1128.
8. Coker A., Arman A., Soylu O., Tezel T., Yildirim A. Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in Turkish population. Int. J. Immunogenet. 2011, 38:201-208.
9. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177.
10. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629.
11. Fan W.H., Liu D.L., Xiao L.M., Xie C.J., Sun S.Y., Zhang J.C. Coronary heart disease and chronic periodontitis: is polymorphism of interleukin-6 gene the common risk factor in a Chinese population?. Oral Dis. 2011, 17:270-276.
12. Fishman D., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
13. Georges J.L., et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde. J. Mol. Med. (Berl) 2001, 79:300-305.
14. Ghazouani L., et al. TNF-alpha -308G>A and IL-6 -174G>C polymorphisms in Tunisian patients with coronary artery disease. Clin. Biochem. 2010, 43:1085-1089.
15. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
16. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557.
17. Hojo Y., Ikeda U., Takahashi M., Shimada K. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 2002, 161:403-408.
18. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., Miller G.J. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur. Heart J. 2001, 22:2243-2252.
19. Kelberman D., et al. Effect of interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb. Haemost. 2004, 92:1122-1128.
20. Libby P. Changing concepts of atherogenesis. J. Intern. Med. 2000, 247:349-358.
21. Licastro F., et al. The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech. Ageing Dev. 2004, 125:575-579.
22. Lieb W., et al. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int. J. Cardiol. 2004, 97:205-212.
23. Maitra A., et al. Polymorphisms in the IL6 gene in Asian Indian families with premature coronary artery disease-the Indian Atherosclerosis Research Study. Thromb. Haemost. 2008, 99:944-950.
24. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer 1959, 22:719.
25. Merino A., et al. Platelet aggregation inhibition blocks C-reactive protein and interleukin-6 (IL-6) elevation after the coronary angioplasty: effect of the -174 G/C IL-6 gene polymorphism. Am. J. Cardiol. 2004, 94:1300-1303.
26. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 2009, 151:264-269. PRISMA Group.
27. Myśliwska J., et al. Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries. Eur. Cytokine Netw. 2006, 17:181-189.
28. Nauck M., Winkelmann B.R., Hoffmann M.M., Böhm B.O., Wieland H., März W. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J. Mol. Med. (Berl) 2002, 80:507-513.
29. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am. J. Cardiol. 2001, 88:10-15.
30. Sarecka B., Zak I., Krauze J. Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease. Clin. Biochem. 2008, 41:467-473.
31. Sekuri C., et al. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort. Coron. Artery Dis. 2007, 18:333-337.
32. Sie M.P., et al. Interleukin 6-174 G/C promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler. Thromb. Vasc. Biol. 2006, 26:212-217.
33. Simons L.A. Interrelations of lipid and lipoproteins with coronary artery disease mortality in 19 countries. Am. J. Cardiol. 1986, 57:5G-10G.
34. Smith A.J., et al. Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism. Clin. Chem. 2008, 54:841-850.
35. Terry C.F., Loukaci V., Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 2000, 275:18138-18144.
36. Trevelyan J., Brull D.J., Needham E.W., Montgomery H.E., Morris A., Mattu R.K. Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene. Am. J. Cardiol. 2004, 94:564-569.
37. Tütün U., et al. Gene polymorphisms in patients below 35years of age who underwent coronary artery bypass surgery. Coron. Artery Dis. 2006, 17:35-39.
38. Vakili H., Ghaderian S.M., Akbarzadeh Najar R., Tabatabaei Panah A.S., Azargashb E. Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction. Coron. Artery Dis. 2011, 22:299-305.
39. Wells G.A., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2011, Ottawa Health Research Institute, www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed Oct 20, 2011).